Synbiotic Health Team Welcomes Mallory Van Haute as Lab Scientist

With a decade’s experience in food and microbiology, Van Haute will help execute on Synbiotic Health’s ambitious R&D program

LINCOLN, Neb.  – October 1, 2021 – Microbiome-based ingredient company Synbiotic Health welcomes team member Mallory Van Haute this week in the role of Laboratory Scientist. Van Haute brings ten years’ scientific experience in food and gastrointestinal microbiology, having worked in multiple academic laboratories at University of Nebraska – Lincoln. She has been Research Manager at the Nebraska Food for Health Center and has more than a dozen peer-reviewed publications.

In the role of Scientist at Synbiotic Health, Van Haute will report to CSO Dr. Zac Lewis and carry out research and development activities in the company’s innovation pipeline. She will lead lab work and bioinformatic projects to guide product development and deliver new health-promoting ingredients to market. She holds an M.S. in Food Science & Technology from University of Nebraska – Lincoln and is nearing completion of her Ph.D.

“Mallory has worked closely with some of our founders for many years, and brings exceptional knowledge and experience in diet-microbiome interactions to our team” says CSO Dr. Zac Lewis. “We could not be happier that she is joining us. Her presence increases our capacity to discover new ecologically advanced probiotic strains, design intelligently paired synbiotics, and rationally target the aspects of human health where our product development approach will yield superior results for consumers.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop targeted microbiome ingredients to support health. Based on over 10 years of research, Synbiotic Health will develop and commercialize Ecologically Advanced Probiotics™ as well as rationally designed Synergistic Synbiotics™.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Kristina Campbell

Kristina@synbiotichealth.com

Thomas Auchtung, PhD, joins Synbiotic Health as Lab Manager

Experienced microbiologist to manage the company’s microbiome-focused research and development platform

LINCOLN, Neb.  – August 3, 2021 – Microbiome-based ingredient company Synbiotic Health is pleased to welcome Dr. Thomas Auchtung to the team in the key role of Laboratory Manager. Auchtung comes to Synbiotic Health with a wealth of microbiology research experience and scientific talent. He holds a PhD from Harvard University and joins the company after spending three years as Research Assistant Professor in the Department of Food Science and Technology at University of Nebraska-Lincoln.

Auchtung will manage internal laboratory operations and external testing to execute on the company’s product development and improvement strategy, as the company prepares to release its first commercially available ingredient, the iVS-1 Advanced Probiotic™ strain. The author of 19 peer-reviewed publications, Auchtung has previously worked in the labs of Joseph Petrosino at Baylor College of Medicine, Robert Britton at Michigan State University, Colleen Cavanaugh at Harvard University, Alan Grossman at MIT, and Robert Hausinger at Michigan State University.

“Tommy brings an impressive breadth of scientific experience from working in leading academic labs,” says Zac Lewis, CSO of Synbiotic Health. “We are delighted to have him join our growing company to help develop our unique portfolio of ecologically-designed ingredients. Having him lead our internal discovery and bench research activities will let us continue to bring truly innovative and disruptive offerings to the market for the long term. This capability will help position us as the leading science-based and data-driven strain provider in the probiotic industry; delivering demonstrably superior ecology-based technology as envisioned by our founders.”

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize Advanced Probiotics™ as well as Synergistic Synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework: how probiotics and other microbiome-based ingredients interact with and influence the resident microbes in the gut. Synbiotic Health’s approach considers the entire ecosystem and the specific traits and functions necessary for microbiome-altering ingredients to perform and improve human health.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic™ – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Kristina Campbell

Kristina@synbiotichealth.com

Synbiotic Health appoints Steve Prescott, MBA, as Senior Vice President, Business Development / Operations

Probiotics industry veteran to lead business strategy for company’s growing product portfolio

LINCOLN, Neb.  – June 10, 2021 – Synbiotic Health, a rapidly growing microbiome nutritional ingredients company, is pleased to announce that Steve Prescott, MBA, has taken on the role of Senior Vice President, Business Development. Prescott has extensive experience in the probiotics industry, having served as Global VP – Marketing and Operations and Global Business Director for leading probiotic producers.

At Synbiotic Health, Prescott will refine and implement the company’s strategy for business operations as he oversees product development, sales and marketing. Initially he will focus on bringing the company’s first commercially available ingredient, iVS-1 Ecologically-Advanced Probiotic™, to market.

“With his broad experience in the industry, Steve Prescott is a great addition to our growing team,” said Tim Brummels, Synbiotic Health CEO. “He’s very knowledgeable about business strategy and has previously brought new products to market. Importantly, since Synbiotic Health is a company that sets itself apart through scientific innovation, his solid technical background will serve him well in this role.”Prescott previously held positions with Probi and DuPont, and has been working in the probiotics industry for 9 years. He holds an MBA from Michigan State University and a MS in Organic Chemistry from Iowa State University.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four well-known microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize advanced probiotics™ and synergistic synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework. That is, how probiotics and other microbiome ingredients interact with and influence the resident microbes in the gut. At Synbiotic Health, its research considers the entire ecosystem and the specific traits and functions necessary for microbiome ingredients to perform and improve human health. The approach has led to novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Tim Brummels

t.brummels@synbiotichealth.com

 

 

Zac Lewis, PhD, Joins Team at Synbiotic Health as Chief Scientific Officer

Will lead its ‘ecologically-advanced’ microbiome research & development efforts

FOR IMMEDIATE RELEASE

LINCOLN, Neb.  – March 16, 2021 – Synbiotic Health is pleased to announce the addition of Dr. Zac Lewis as its Chief Scientific Officer. Dr. Lewis’s responsibilities will be to lead the build out and implementation of Synbiotic Health’s research & development program. Dr. Lewis will also serve as a liaison between Synbiotic Health’s Scientific Founders and its commercial efforts. A primary focus will be to develop and introduce microbiome-based ingredients using Synbiotic Health’s unique ‘ecological’ approach that has resulted in novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

“We’re delighted to have Dr. Lewis join the team at Synbiotic Health,” said Tim Brummels, CEO/President with Synbiotic Health. “He brings the experience necessary to lead research efforts as well as commercialize our microbiome ingredients, and believes strongly in the value of using an ecological approach in product development.”

Dr. Lewis previously was an associate research fellow and microbiome subject matter expert with The Clorox Company working on the Renew Life brand, and has been involved in microbiome research for over 15 years. Dr. Lewis has authored or contributed to over 20 research publications and has spoken at a number of microbiome-related conferences. His key skill set includes probiotic and prebiotic product design, microbial ecology, bioinformatics, microbiology, and molecular biology. He holds a PhD in Microbiology from University of California, Davis and a BS in Microbiology from Brigham Young University.

About Synbiotic Health

Synbiotic Health was founded in 2018 by four noted microbiome research scientists to develop ecologically-advanced microbiome ingredients for improved health. Based on over 10 years of research, Synbiotic Health will commercialize advanced probiotics™ and synergistic synbiotics™ – complementary combinations of probiotics with fiber and/or prebiotics.

The foundation of Synbiotic Health’s research focuses on understanding the gut environment and its ecological framework. That is, how probiotics and other microbiome ingredients interact with and influence the resident microbes in the gut. At Synbiotic Health, its research considers the entire ecosystem and the specific traits and functions necessary for microbiome ingredients to perform and improve human health. The approach has led to novel discovery platforms as well as ecologically-advanced probiotic strains and synergistic synbiotics™.

The Scientific Founder team includes Dr. Robert Hutkins and Dr. Andy Benson with the University of Nebraska-Lincoln’s Food for Health Center; Dr. Jens Walter with APC Microbiome Ireland, University College Cork; and Dr. Tom Burkey, an animal scientist with the University of Nebraska-Lincoln.

Synbiotic Health will commercialize its first ecologically-advanced probiotic – iVS-1™ Advanced Probiotic – in 2021 and is in the process of completing additional clinical studies to further define the health benefits of additional novel ingredients.

For more information, please contact:

Tim Brummels

t.brummels@synbiotichealth.com

                                                

 

Synbiotic Health Signs Licensing Agreement to Enable Development of Unique Synergistic Synbiotics

This is a press release from Synbiotic Health, distributed through Cision PR Newswire

LINCOLN, NE, Nov. 21, 2019 /PRNewswire/ – Synbiotics—combinations of probiotics and prebiotics—are a rapidly growing category of natural health products. However, researchers are only now beginning to study how synbiotics should be optimally formulated. Recently, Synbiotic Health announced the signing of a commercial agreement with NUtech Ventures, the nonprofit technology commercialization affiliate of the University of Nebraska, which grants the company worldwide exclusive rights to specially developed strains for use in formulating high-quality synergistic synbiotic products.

This licensing agreement emerged from research at the Nebraska Food for Health Center and University of Nebraska–Lincoln’s department of food science and technology. The technology was developed by globally leading probiotic and prebiotic researchers, including Dr. Bob Hutkins and Dr. Andy Benson of the Nebraska Food for Health Center, animal scientist Dr. Tom Burkey, and Dr. Jens Walter from the University of Alberta.

A typical synbiotic is designed to deliver the separate health benefits of its constituent probiotic and prebiotic. Synbiotic Health will now be able to formulate a new generation of products in which the probiotic microbe is selectively enriched and stimulated by the paired prebiotic substrate.

“This agreement will allow Synbiotic Health to lead the way in developing and commercializing a unique type of nutritional ingredient,” says Tim Brummels, president and CEO of Synbiotic Health. “This strong scientific foundation allows us to develop products with demonstrated synergy between the probiotic and the prebiotic. We are confident this will make the health effects more reliable, adding value for the consumer.”

The company’s first product, targeting food & beverage and nutritional supplement manufacturers, will launch in fall 2020. Its clinical program will commence in early 2020.

Brummels says, “Leading nutritional companies are considering the gut microbiome and its ability to impact human health as integral to its product development strategy. We are meeting this need head-on with scientifically robust solutions.”

Dr. Andy Benson, a University of Nebraska Presidential Chair and Director of the Nebraska Food for Health Center, says, “The agreement represents the center’s commitment to translation and commercialization of its research outputs. We hope it serves as a model to stimulate interest in bringing some of the university’s great discoveries to the marketplace.”

About Synbiotic Health

Headquartered at the Nebraska Innovation Campus, Synbiotic Health is a natural nutritional ingredients company. The founders, which include researchers at the University of Nebraska, formed Synbiotic Health in 2019, with the goal of developing scientifically- and clinically-tested synergistic combinations of probiotics with prebiotics.

Synbiotic Health aims to be the leader in the innovation and development of the highest quality synergistic synbiotics that will provide consistent health benefits as demonstrated through clinical evidence.

Visit synbiotichealth.com for information and developments.

For more information on the Nebraska Food for Health Center, visit its web site at foodforhealth.unl.edu.

SOURCE Synbiotic Health

Faculty-Led Startup Takes Aim at Improving Gut Health

This is a press release from NUtech Ventures, first published on the website of University of Nebraska-Lincoln

Nebraska faculty have founded a university spin-off company, Synbiotic Health, to develop a combination of beneficial gut bacteria and the fuel that feeds them.

A synbiotic, the company’s namesake, refers to the mixture of beneficial bacteria and fiber-like fuel that may be more effective at delivering health benefits when paired together. Working with NUtech Ventures, the university’s technology commercialization affiliate, the startup company has licensed its first synbiotic strains and plans to begin human clinical trials next year.

The company’s founding members include Nebraska’s Bob Hutkins, Andy Benson and Tom Burkey, as well as the University of Alberta’s Jens Walters and CEO Tim Brummels. The team formed Synbiotic Health with the goal of commercializing synbiotic combinations as ingredients for food and beverage companies.

The Nebraska researchers have long been studying how fiber-like prebiotics can support the growth of probiotics, beneficial bacteria that reside in the gastrointestinal tract. Their research also focuses on pairing the right prebiotic with the right probiotic, which may help good bacteria stick around long enough to have health benefits.

“We’re excited to provide a scientific foundation that supports the commercialization of safe, effective synbiotics,” Brummels said. “The gut microbiome, and its impact on human health, is a key product-development platform for a number of leading nutritional companies.”

According to food scientist Andy Benson, the partnership with Synbiotic Health is also an important achievement for the Nebraska Food for Health Center. The center focuses on developing foods with proven health benefits, particularly those that affect the human gut microbiome.

“This partnership demonstrates the center’s commitment to translating and commercializing research-based products,” said Benson, presidential chair and center director. “These synbiotics are a rapidly emerging class of ‘next generation’ probiotics that can ultimately improve human and animal health.”

Synbiotic Health Opens Laboratory at University of Nebraska

Synbiotic Health announces it has signed a lease on a laboratory space at the Biotech Connector space located at the NUtech Innovation Center on the University of Nebraska’s Lincoln campus. The new lab will allow the company’s science team to continue its efforts to advance the development of a unique class of synergistic synbiotics.

The company’s inaugural synbiotic nutritional ingredient is forthcoming in 2020.

Synbiotic Health Scientists Publish Scientific Paper on Unique Synbiotic Formulation Strategy

University of Nebraska professor and Synbiotic Health co-founding scientist Dr. Robert Hutkins is leading the development of a unique strategy to formulate synergistic synbiotics—and this innovative technique was recently published in an academic paper in the American Society for Microbiology Journal. The paper, entitled “An In Vitro Enrichment Strategy for Formulating Synergistic Synbiotics”, is co-authored by Hutkins along with Car Reen Kok, David Fabian Gomez Quintero, Clement Niyirora, Devin Rose, and Amanda Li.

“To date, demonstrating synergistic effects of probiotic and prebiotic ingredients has been scientifically challenging,”— says Tim Brummels, CEO of Synbiotic Health. “This publication pioneers and approach that shows it’s possible to improve on the synbiotic products currently available on the market. We look forward to continuing our scientific work, creating unique synbiotic formulations to support human health.”

The paper can be found here.

Synbiotic Health Establishes Headquarters at the Nebraska Innovation Campus

Synbiotic Health has opened an office at Nebraska Innovation Campus (NIC), adjacent to the University of Nebraska-Lincoln. NIC is a public/private research campus connected with the University of Nebraska—designed to connect the talents of experts, industry, and the university to create a culture of collaboration and innovation.

The office will serve as the company headquarters as its science team continues its R&D efforts on a new class of synergistic synbiotics.

Synbiotic Health Appoints Tim Brummels as President and CEO

The Synbiotic Health team is pleased to announce that Tim Brummels has been appointed Chair of the Board, CEO, and President. Brummels is a 30-year entrepreneur, executive officer, board member, and investor for natural health ingredient companies.

Brummels and has worked with companies that range from start-ups to Fortune 500 companies, including his own consultancy, Edgewater Company, ConAgra Foods and Berkshire Hathaway Homestate Company. Brummels is also a co-founder and current board member of Prenexus Health, Inc., having previously served the company as CEO and President. His approach to achieving market success centers around strategic planning, capitalization, financing and measurable execution plans.

Brummels says, “As we move into an era of learning more about the human microbiome, new opportunities are emerging for modulating the gut microbiome to achieve better health. I look forward to working with this world-leading team of scientific experts who are pioneering new approaches and products.” See here for more on Tim Brummels.